CIK 0001069899 · Large accelerated filer
PHIBRO ANIMAL HEALTH CORP
Sign in to watch- Ticker
- PAHC
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Jun 30
- Incorporated
- DE
- Entity type
- operating
- EIN
- 131840497
- Phone
- 201-329-7300
- Business address
- GLENPOINTE CENTRE EAST, 3RD FLOOR, 300 FRANK W. BURR BLVD., SUITE 21, TEANECK, NJ, 07666
- Former names
- PHILIPP BROTHERS CHEMICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-11-10 | BENDHEIM JACK President and CEO | Sale 10b5-1 | −14,086 | $44.91 | $633K | 40,670 |
| 2025-11-10 | BENDHEIM JACK President and CEO | Sale 10b5-1 | −19,773 | $45.81 | $906K | 20,897 |
| 2025-11-10 | BENDHEIM JACK President and CEO | Sale 10b5-1 | −320 | $46.36 | $15K | 20,577 |
| 2025-11-07 | BENDHEIM JACK President and CEO | Sale 10b5-1 | −3,520 | $42.86 | $151K | 58,880 |
| 2025-11-05 | BENDHEIM JACK President and CEO | Sale 10b5-1 | −2,548 | $40.98 | $104K | 63,372 |
| 2025-11-05 | BENDHEIM JACK President and CEO | Sale 10b5-1 | −972 | $41.83 | $41K | 62,400 |
| 2025-11-04 | BENDHEIM JACK President and CEO | Conversion 10b5-1 | +25,000 | 69,440 | ||
| 2025-11-04 | BENDHEIM JACK President and CEO | Sale 10b5-1 | −2,996 | $43.01 | $129K | 66,444 |
| 2025-11-04 | BENDHEIM JACK President and CEO | Sale 10b5-1 | −524 | $43.62 | $23K | 65,920 |
| 2025-11-04 | BENDHEIM JACK President and CEO | Conversion · Class B Common Stock 10b5-1 | −25,000 | 20,061,034 | ||
| 2025-10-30 | BENDHEIM JACK President and CEO | Sale 10b5-1 | −3,520 | $41.07 | $145K | 44,440 |
| 2025-10-29 | BENDHEIM JACK President and CEO | Sale 10b5-1 | −3,520 | $41.66 | $147K | 47,960 |
| 2025-10-28 | BENDHEIM JACK President and CEO | Sale 10b5-1 | −3,520 | $41.56 | $146K | 51,480 |
| 2025-10-24 | BENDHEIM JACK President and CEO | Sale 10b5-1 | −3,520 | $41.75 | $147K | 55,000 |
| 2025-10-23 | BENDHEIM JACK President and CEO | Sale 10b5-1 | −3,520 | $40.18 | $141K | 58,520 |
| 2025-10-22 | BENDHEIM JACK President and CEO | Sale 10b5-1 | −11,859 | $40.27 | $478K | 62,040 |
| 2025-10-21 | BENDHEIM JACK President and CEO | Conversion 10b5-1 | +50,000 | 73,899 | ||
| 2025-10-21 | BENDHEIM JACK President and CEO | Conversion · Class B Common Stock 10b5-1 | −50,000 | 20,086,034 | ||
| 2025-10-20 | BENDHEIM JACK President and CEO | Sale 10b5-1 | −16,075 | $40.38 | $649K | 23,899 |
| 2025-10-17 | BENDHEIM JACK President and CEO | Sale 10b5-1 | −700 | $40.03 | $28K | 39,974 |
Page 8 of 18 · 343 trades